Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf3
|
ENSMUSG00000003051.7 | E74-like factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_135258064_135259220 | Elf3 | 74 | 0.952405 | 0.54 | 9.7e-06 | Click! |
chr1_135257446_135257838 | Elf3 | 7 | 0.961216 | 0.41 | 1.1e-03 | Click! |
chr1_135260842_135260993 | Elf3 | 2349 | 0.182812 | 0.40 | 1.7e-03 | Click! |
chr1_135256598_135257369 | Elf3 | 666 | 0.568257 | 0.26 | 4.3e-02 | Click! |
chr1_135255599_135256514 | Elf3 | 1593 | 0.253932 | 0.24 | 6.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_97566192_97567945 | 5.10 |
Lum |
lumican |
1940 |
0.32 |
chr9_107975554_107976970 | 4.86 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr16_95456632_95459094 | 3.81 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr4_62515406_62516411 | 3.76 |
Alad |
aminolevulinate, delta-, dehydratase |
3973 |
0.13 |
chr18_75384437_75388058 | 3.67 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr5_30913519_30915234 | 3.62 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chrX_170676003_170677019 | 3.48 |
Asmt |
acetylserotonin O-methyltransferase |
3867 |
0.35 |
chr18_35847749_35850271 | 3.34 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr16_76679845_76680911 | 3.26 |
Gm45029 |
predicted gene 45029 |
135 |
0.97 |
chrX_53053916_53055220 | 3.21 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr8_121088119_121090419 | 3.16 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr14_63242982_63243456 | 3.09 |
Gata4 |
GATA binding protein 4 |
2029 |
0.3 |
chr18_11049995_11051717 | 3.06 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr1_51292465_51292852 | 3.04 |
Cavin2 |
caveolae associated 2 |
3532 |
0.24 |
chr16_38362450_38363226 | 3.00 |
Popdc2 |
popeye domain containing 2 |
593 |
0.63 |
chr9_114562610_114564528 | 2.95 |
Trim71 |
tripartite motif-containing 71 |
800 |
0.6 |
chr7_31040855_31042728 | 2.90 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr11_88998963_89000826 | 2.89 |
Trim25 |
tripartite motif-containing 25 |
518 |
0.65 |
chr13_111867705_111868762 | 2.81 |
Gm15326 |
predicted gene 15326 |
297 |
0.86 |
chr9_69454872_69455904 | 2.78 |
Anxa2 |
annexin A2 |
1322 |
0.26 |
chr13_106835269_106836682 | 2.77 |
Lrrc70 |
leucine rich repeat containing 70 |
173 |
0.7 |
chr17_85686512_85689764 | 2.75 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr8_27106426_27107774 | 2.72 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
7033 |
0.12 |
chrX_143825863_143827628 | 2.68 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr13_56024595_56025288 | 2.68 |
Gm47072 |
predicted gene, 47072 |
5293 |
0.21 |
chr19_46304366_46306224 | 2.66 |
4833438C02Rik |
RIKEN cDNA 4833438C02 gene |
310 |
0.52 |
chr18_32557788_32558922 | 2.65 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr18_38928285_38929463 | 2.65 |
Fgf1 |
fibroblast growth factor 1 |
283 |
0.92 |
chr1_172501767_172503923 | 2.65 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr10_58371395_58372247 | 2.63 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
367 |
0.87 |
chr8_123978308_123979538 | 2.62 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr5_75148315_75152589 | 2.62 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr16_89830219_89830776 | 2.58 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
7378 |
0.3 |
chr10_99912846_99913873 | 2.56 |
Gm47579 |
predicted gene, 47579 |
47339 |
0.13 |
chr1_36272569_36273936 | 2.54 |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
183 |
0.93 |
chr2_170150859_170151260 | 2.48 |
Zfp217 |
zinc finger protein 217 |
2956 |
0.37 |
chr4_115059803_115061295 | 2.45 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
1041 |
0.47 |
chr14_101841178_101841822 | 2.42 |
Lmo7 |
LIM domain only 7 |
681 |
0.79 |
chr11_86586191_86587628 | 2.40 |
Vmp1 |
vacuole membrane protein 1 |
28 |
0.97 |
chr7_19821864_19823009 | 2.40 |
Bcl3 |
B cell leukemia/lymphoma 3 |
279 |
0.77 |
chr6_83068298_83071797 | 2.38 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr11_117779316_117780928 | 2.37 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr6_146220976_146221548 | 2.36 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
6281 |
0.26 |
chr3_79885722_79887545 | 2.36 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr1_180829946_180830979 | 2.33 |
Gm24836 |
predicted gene, 24836 |
2307 |
0.16 |
chrX_137118132_137120673 | 2.33 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr6_144822659_144823226 | 2.33 |
Gm22792 |
predicted gene, 22792 |
19310 |
0.19 |
chr2_166030364_166031781 | 2.31 |
Ncoa3 |
nuclear receptor coactivator 3 |
16846 |
0.15 |
chr3_116563017_116563467 | 2.31 |
Lrrc39 |
leucine rich repeat containing 39 |
264 |
0.81 |
chr11_95840624_95841423 | 2.29 |
Abi3 |
ABI gene family, member 3 |
1075 |
0.28 |
chr7_19796098_19797425 | 2.28 |
Cblc |
Casitas B-lineage lymphoma c |
32 |
0.93 |
chr7_83654607_83655449 | 2.28 |
Il16 |
interleukin 16 |
297 |
0.84 |
chr7_142658126_142659753 | 2.26 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr15_5107710_5108629 | 2.26 |
Card6 |
caspase recruitment domain family, member 6 |
315 |
0.81 |
chr1_171767462_171768093 | 2.24 |
Slamf1 |
signaling lymphocytic activation molecule family member 1 |
622 |
0.59 |
chr17_86300838_86301701 | 2.24 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
14091 |
0.27 |
chr7_45238275_45239242 | 2.24 |
Cd37 |
CD37 antigen |
38 |
0.92 |
chr1_87620304_87621692 | 2.24 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr9_111055888_111057545 | 2.22 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr3_129881133_129881711 | 2.22 |
Pla2g12a |
phospholipase A2, group XIIA |
238 |
0.9 |
chr2_103958009_103958847 | 2.21 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr15_66560466_66561298 | 2.20 |
Tmem71 |
transmembrane protein 71 |
221 |
0.94 |
chr1_58802310_58803113 | 2.20 |
Casp8 |
caspase 8 |
58 |
0.96 |
chr6_143750987_143751675 | 2.19 |
1700060C16Rik |
RIKEN cDNA 1700060C16 gene |
100043 |
0.08 |
chr11_96318060_96319501 | 2.19 |
Hoxb4 |
homeobox B4 |
513 |
0.51 |
chr8_70609276_70610571 | 2.18 |
Gm45546 |
predicted gene 45546 |
502 |
0.53 |
chr10_34483356_34484742 | 2.17 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr3_69040430_69041588 | 2.16 |
Trim59 |
tripartite motif-containing 59 |
3706 |
0.15 |
chr11_70228540_70230880 | 2.16 |
Bcl6b |
B cell CLL/lymphoma 6, member B |
29 |
0.93 |
chr16_25802324_25803670 | 2.16 |
Trp63 |
transformation related protein 63 |
1081 |
0.63 |
chr1_131278585_131279837 | 2.16 |
Ikbke |
inhibitor of kappaB kinase epsilon |
395 |
0.77 |
chr18_32538131_32539106 | 2.15 |
Gypc |
glycophorin C |
3200 |
0.25 |
chr11_69399334_69402458 | 2.14 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr7_24372341_24372746 | 2.13 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
2205 |
0.15 |
chr10_80344213_80345627 | 2.10 |
Adamtsl5 |
ADAMTS-like 5 |
318 |
0.71 |
chr10_43594103_43594363 | 2.10 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
794 |
0.55 |
chr19_25381686_25382798 | 2.09 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
13061 |
0.21 |
chr4_45763336_45764521 | 2.08 |
Gm12409 |
predicted gene 12409 |
295 |
0.87 |
chr7_143007094_143009025 | 2.06 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr7_19290671_19291896 | 2.06 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr4_43507951_43509367 | 2.06 |
Gm12454 |
predicted gene 12454 |
65 |
0.55 |
chr6_30172641_30174725 | 2.05 |
Rncr4 |
retina expressed non-coding RNA 4 |
790 |
0.51 |
chr17_31207686_31208032 | 2.05 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
14 |
0.96 |
chr2_119299920_119301063 | 2.04 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
11704 |
0.1 |
chr11_8502774_8504068 | 2.03 |
Tns3 |
tensin 3 |
34746 |
0.23 |
chr3_89136417_89137539 | 2.01 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr18_54422355_54422833 | 2.00 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
299 |
0.93 |
chr11_83281871_83282887 | 1.99 |
Slfn14 |
schlafen 14 |
4347 |
0.1 |
chr11_68956320_68957720 | 1.98 |
Arhgef15 |
Rho guanine nucleotide exchange factor (GEF) 15 |
460 |
0.64 |
chr7_104244475_104245215 | 1.98 |
Trim34a |
tripartite motif-containing 34A |
352 |
0.71 |
chr6_58642449_58642948 | 1.97 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2116 |
0.36 |
chr4_46040988_46042013 | 1.97 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chrX_73909796_73911465 | 1.97 |
Arhgap4 |
Rho GTPase activating protein 4 |
599 |
0.57 |
chr5_124049658_124050948 | 1.96 |
Gm43661 |
predicted gene 43661 |
2049 |
0.18 |
chr10_97479376_97480642 | 1.96 |
Dcn |
decorin |
400 |
0.88 |
chr16_93682811_93684143 | 1.95 |
Cbr3 |
carbonyl reductase 3 |
218 |
0.91 |
chr8_88300415_88300996 | 1.93 |
Adcy7 |
adenylate cyclase 7 |
326 |
0.89 |
chr6_31114239_31115170 | 1.93 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
3784 |
0.15 |
chr11_35024565_35025036 | 1.92 |
Slit3 |
slit guidance ligand 3 |
96424 |
0.08 |
chr10_108595779_108596540 | 1.92 |
Syt1 |
synaptotagmin I |
40805 |
0.18 |
chr14_27237814_27239092 | 1.90 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr16_36934847_36935880 | 1.89 |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
380 |
0.77 |
chr13_38151091_38152938 | 1.88 |
Gm10129 |
predicted gene 10129 |
222 |
0.82 |
chr18_38188855_38189945 | 1.88 |
Pcdh1 |
protocadherin 1 |
13763 |
0.13 |
chr7_101377838_101379825 | 1.88 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr9_79977295_79978179 | 1.87 |
Filip1 |
filamin A interacting protein 1 |
67 |
0.97 |
chr6_24598951_24599156 | 1.87 |
Lmod2 |
leiomodin 2 (cardiac) |
1291 |
0.38 |
chr19_4558659_4559358 | 1.86 |
Pcx |
pyruvate carboxylase |
198 |
0.92 |
chr14_77904388_77905097 | 1.85 |
Epsti1 |
epithelial stromal interaction 1 (breast) |
335 |
0.9 |
chr1_171437287_171438855 | 1.85 |
F11r |
F11 receptor |
492 |
0.63 |
chr4_83050960_83052655 | 1.84 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
360 |
0.89 |
chr15_59263361_59263897 | 1.84 |
Gm36617 |
predicted gene, 36617 |
11767 |
0.16 |
chr5_145113839_145115039 | 1.84 |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
123 |
0.92 |
chr6_48707880_48708301 | 1.84 |
Gimap6 |
GTPase, IMAP family member 6 |
106 |
0.91 |
chr16_44015370_44016774 | 1.84 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr17_69395929_69396464 | 1.84 |
Gm49894 |
predicted gene, 49894 |
11988 |
0.14 |
chr9_92251154_92251727 | 1.83 |
Plscr1 |
phospholipid scramblase 1 |
1098 |
0.45 |
chr12_80885315_80886140 | 1.83 |
Susd6 |
sushi domain containing 6 |
17019 |
0.13 |
chr11_22376584_22377158 | 1.83 |
Rpsa-ps3 |
ribosomal protein SA, pseudogene 3 |
9421 |
0.22 |
chr18_64952593_64952749 | 1.82 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
24160 |
0.18 |
chr18_15345788_15346105 | 1.81 |
A830021F12Rik |
RIKEN cDNA A830021F12 gene |
5988 |
0.22 |
chr2_35691764_35692937 | 1.81 |
Dab2ip |
disabled 2 interacting protein |
17 |
0.98 |
chr15_83432069_83433241 | 1.80 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
160 |
0.94 |
chr13_94806505_94807110 | 1.79 |
Tbca |
tubulin cofactor A |
10927 |
0.19 |
chr6_145121842_145122511 | 1.78 |
Lrmp |
lymphoid-restricted membrane protein |
395 |
0.81 |
chr18_10787357_10787713 | 1.78 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
1652 |
0.2 |
chr14_26441045_26441600 | 1.78 |
Slmap |
sarcolemma associated protein |
1333 |
0.39 |
chr18_12256920_12257106 | 1.78 |
Ankrd29 |
ankyrin repeat domain 29 |
14684 |
0.14 |
chr12_53032902_53033993 | 1.78 |
n-R5s58 |
nuclear encoded rRNA 5S 58 |
13379 |
0.3 |
chr10_45048086_45048775 | 1.78 |
Prep |
prolyl endopeptidase |
18773 |
0.15 |
chr3_51226325_51226945 | 1.78 |
Noct |
nocturnin |
2165 |
0.24 |
chr7_110773542_110774597 | 1.77 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr4_83315229_83315966 | 1.76 |
Ttc39b |
tetratricopeptide repeat domain 39B |
8592 |
0.19 |
chr10_79988072_79989720 | 1.76 |
Cnn2 |
calponin 2 |
273 |
0.76 |
chr3_84472667_84473268 | 1.76 |
Fhdc1 |
FH2 domain containing 1 |
6015 |
0.25 |
chr10_127748635_127749453 | 1.75 |
Gpr182 |
G protein-coupled receptor 182 |
2688 |
0.12 |
chr4_154024404_154026596 | 1.75 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr13_59821306_59822207 | 1.74 |
Tut7 |
terminal uridylyl transferase 7 |
832 |
0.41 |
chr17_26844031_26845183 | 1.74 |
Nkx2-5 |
NK2 homeobox 5 |
402 |
0.75 |
chr6_60944275_60945483 | 1.74 |
Mmrn1 |
multimerin 1 |
401 |
0.88 |
chr8_80497324_80498362 | 1.73 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr2_25195300_25197035 | 1.73 |
Tor4a |
torsin family 4, member A |
592 |
0.43 |
chr5_75975825_75977229 | 1.72 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr8_85379656_85380136 | 1.72 |
Mylk3 |
myosin light chain kinase 3 |
1082 |
0.42 |
chr8_88635072_88636330 | 1.72 |
Snx20 |
sorting nexin 20 |
400 |
0.84 |
chr4_115052274_115053340 | 1.71 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
3619 |
0.19 |
chr2_30772547_30773023 | 1.71 |
1700001O22Rik |
RIKEN cDNA 1700001O22 gene |
23879 |
0.11 |
chr6_31125380_31126701 | 1.70 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr10_63457257_63458786 | 1.70 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr9_85324630_85325846 | 1.70 |
Tent5a |
terminal nucleotidyltransferase 5A |
1886 |
0.28 |
chr12_105012986_105013545 | 1.70 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
3456 |
0.13 |
chr12_105036783_105037593 | 1.70 |
Glrx5 |
glutaredoxin 5 |
1972 |
0.18 |
chr2_173026008_173027110 | 1.70 |
Rbm38 |
RNA binding motif protein 38 |
3509 |
0.16 |
chr7_130576739_130577783 | 1.70 |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
177 |
0.94 |
chr9_25048281_25048834 | 1.69 |
Gm48256 |
predicted gene, 48256 |
8493 |
0.17 |
chr1_74000460_74000747 | 1.69 |
Tns1 |
tensin 1 |
964 |
0.63 |
chr7_100494865_100496416 | 1.69 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr18_58557873_58558723 | 1.68 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
2041 |
0.43 |
chr1_174175177_174176129 | 1.67 |
Spta1 |
spectrin alpha, erythrocytic 1 |
2877 |
0.14 |
chr14_63244119_63245953 | 1.67 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr18_10532272_10533276 | 1.66 |
Gm24894 |
predicted gene, 24894 |
18632 |
0.16 |
chr15_76197527_76199931 | 1.66 |
Plec |
plectin |
520 |
0.59 |
chr11_87756102_87757558 | 1.66 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr7_133114831_133116529 | 1.65 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr8_36608403_36609754 | 1.65 |
Dlc1 |
deleted in liver cancer 1 |
4796 |
0.31 |
chr19_53681987_53682340 | 1.63 |
Rbm20 |
RNA binding motif protein 20 |
4857 |
0.21 |
chr1_58795219_58796071 | 1.63 |
Casp8 |
caspase 8 |
168 |
0.92 |
chr1_131232374_131233673 | 1.62 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
552 |
0.67 |
chrX_48143101_48144179 | 1.61 |
Sash3 |
SAM and SH3 domain containing 3 |
2796 |
0.26 |
chr10_93294354_93295420 | 1.61 |
Elk3 |
ELK3, member of ETS oncogene family |
15924 |
0.16 |
chr4_144404354_144405079 | 1.61 |
Pramef12os |
PRAME family member 12, opposite strand |
152 |
0.91 |
chr9_32341364_32342112 | 1.61 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
2499 |
0.25 |
chr5_75152837_75154692 | 1.61 |
Gm42802 |
predicted gene 42802 |
111 |
0.58 |
chr7_45523041_45524800 | 1.60 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr8_122546551_122549259 | 1.60 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr15_84719703_84721036 | 1.60 |
Gm20556 |
predicted gene, 20556 |
103 |
0.74 |
chr13_119961525_119962443 | 1.60 |
Gm20784 |
predicted gene, 20784 |
260 |
0.85 |
chr6_117919309_117919901 | 1.60 |
Gm43863 |
predicted gene, 43863 |
1883 |
0.19 |
chr5_139732367_139733376 | 1.60 |
Micall2 |
MICAL-like 2 |
37 |
0.97 |
chr3_79180890_79182068 | 1.60 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
139 |
0.96 |
chr7_80386817_80388333 | 1.59 |
Fes |
feline sarcoma oncogene |
156 |
0.91 |
chr16_11008201_11009347 | 1.59 |
Gm24961 |
predicted gene, 24961 |
14388 |
0.1 |
chr2_128363858_128364681 | 1.59 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
30401 |
0.17 |
chr4_62514007_62514398 | 1.58 |
Alad |
aminolevulinate, delta-, dehydratase |
5679 |
0.12 |
chr13_109633845_109634469 | 1.58 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1377 |
0.62 |
chr1_120258993_120259308 | 1.58 |
Steap3 |
STEAP family member 3 |
6105 |
0.26 |
chr10_19062212_19063096 | 1.58 |
1700124M09Rik |
RIKEN cDNA 1700124M09 gene |
24524 |
0.14 |
chr2_121441930_121443212 | 1.58 |
Ell3 |
elongation factor RNA polymerase II-like 3 |
30 |
0.93 |
chr5_122104473_122104883 | 1.57 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
765 |
0.56 |
chr12_78980165_78980825 | 1.57 |
Tmem229b |
transmembrane protein 229B |
268 |
0.91 |
chr11_70026049_70028279 | 1.57 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
165 |
0.87 |
chr15_81511563_81512296 | 1.57 |
Gm5218 |
predicted gene 5218 |
12384 |
0.13 |
chr17_12744243_12744576 | 1.56 |
Airn |
antisense Igf2r RNA |
3011 |
0.18 |
chr2_72287179_72288372 | 1.56 |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
1981 |
0.32 |
chr5_64807638_64809344 | 1.55 |
Klf3 |
Kruppel-like factor 3 (basic) |
3848 |
0.17 |
chr13_32965217_32966457 | 1.55 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
334 |
0.84 |
chr9_44579315_44579766 | 1.55 |
Gm47230 |
predicted gene, 47230 |
68 |
0.93 |
chr10_4611597_4612860 | 1.55 |
Esr1 |
estrogen receptor 1 (alpha) |
207 |
0.95 |
chr2_167688724_167690153 | 1.54 |
Tmem189 |
transmembrane protein 189 |
384 |
0.52 |
chr9_53356749_53357123 | 1.54 |
Exph5 |
exophilin 5 |
15747 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.5 | 4.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.5 | 4.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.2 | 3.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.2 | 5.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 4.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 3.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.1 | 3.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.9 | 1.8 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.9 | 2.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 2.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.9 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 2.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 2.4 | GO:0072276 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.8 | 2.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 3.1 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.8 | 2.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.8 | 2.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.8 | 0.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.7 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 4.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.7 | 2.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.7 | 2.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 0.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.7 | 2.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 2.2 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.7 | 1.4 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.7 | 2.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 2.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.7 | 2.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 2.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 2.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.6 | 1.9 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 4.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 1.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.6 | 1.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 1.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 1.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 1.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 2.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 1.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 2.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.5 | 1.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 2.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.5 | 2.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 1.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 2.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 1.4 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 1.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.5 | 1.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 1.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 1.4 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 2.3 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.5 | 1.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 0.5 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 1.8 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.4 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 0.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 1.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 3.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 1.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 2.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 3.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 0.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 1.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 4.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.4 | 1.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 0.4 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.4 | 1.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 0.7 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 0.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.4 | 1.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 2.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 1.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 0.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 0.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 1.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 1.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.7 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 2.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 1.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.7 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.3 | 1.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.3 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 1.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 1.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 1.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 1.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 0.9 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 3.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 1.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.6 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 1.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 2.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.2 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 2.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.6 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 1.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 2.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 0.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 2.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 5.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.3 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 2.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.3 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 2.8 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 3.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.3 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 4.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.7 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 1.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 2.6 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.2 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.5 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 1.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 2.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.5 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.4 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.9 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 1.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 1.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 0.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.2 | 0.7 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 2.6 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.6 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 3.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.4 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 1.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 1.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 2.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 2.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 0.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 2.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.6 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 1.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.6 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.8 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 3.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.4 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 0.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.2 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.6 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.2 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 3.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 1.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 3.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 1.3 | GO:0072575 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.2 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.2 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 1.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.2 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.2 | 1.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 2.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 0.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 1.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.3 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.2 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.3 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 2.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 3.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 2.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.2 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 0.9 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 0.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.5 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 3.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 1.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.6 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 1.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.3 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.3 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.4 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 1.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 1.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.0 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 1.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.5 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.1 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.4 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.7 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.1 | 2.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 1.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 1.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 1.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.8 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.3 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 1.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.2 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.2 | GO:1905048 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) regulation of metallopeptidase activity(GO:1905048) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 1.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 1.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 3.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 1.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.2 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.1 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 1.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.8 | GO:0002287 | alpha-beta T cell activation involved in immune response(GO:0002287) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 1.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.6 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.5 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 1.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.1 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.5 | GO:0019627 | urea metabolic process(GO:0019627) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.7 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 1.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.3 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 1.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 1.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 2.5 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.9 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 1.0 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.1 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.1 | GO:0009118 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.1 | 0.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.5 | GO:0051153 | regulation of striated muscle cell differentiation(GO:0051153) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.6 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.0 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.0 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.2 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 1.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.7 | GO:0001707 | mesoderm formation(GO:0001707) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.2 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0019076 | viral release from host cell(GO:0019076) |
0.0 | 1.5 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 1.9 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.2 | GO:0072527 | pyrimidine nucleotide metabolic process(GO:0006220) pyrimidine-containing compound metabolic process(GO:0072527) |
0.0 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.1 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.5 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.0 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.3 | GO:0098534 | centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.0 | 0.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.0 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.3 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.5 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 1.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.6 | 1.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 4.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 2.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 10.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 3.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 7.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 1.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 4.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 0.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 14.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 2.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 2.1 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 10.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 1.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 2.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 2.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 2.3 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 2.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 8.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 1.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.8 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 5.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 4.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 2.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 4.7 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 7.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 20.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 3.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 3.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 14.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.6 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 4.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 2.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 1.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 4.4 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 3.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.7 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 4.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 3.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 3.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 1.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 2.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 1.4 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 4.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.0 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 2.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.2 | 5.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.9 | 2.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.9 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 2.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 3.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 2.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 2.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 2.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 6.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 2.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 2.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.5 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 2.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 2.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 2.0 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 2.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 3.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 0.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 1.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 1.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 1.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 1.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 2.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 4.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 3.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 3.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 2.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 0.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 6.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 9.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 2.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 1.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.9 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 2.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 4.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 2.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 2.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 3.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 2.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.7 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 1.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 3.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 2.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 5.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 1.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 2.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 3.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 1.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 5.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 9.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 2.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 2.3 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.5 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 1.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.9 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 6.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 2.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 3.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 2.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 1.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.3 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 1.4 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 7.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 1.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 1.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 1.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 1.3 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 7.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 11.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 11.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 11.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 12.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 5.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 5.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 8.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 5.5 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 5.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 2.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 5.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 5.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 3.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 4.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 4.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 9.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 7.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 6.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 5.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 8.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 4.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 3.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 8.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 2.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 3.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 2.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 3.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 5.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 1.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 3.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 7.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 5.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 16.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 2.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 7.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 3.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 9.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 3.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 1.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 3.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 1.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 2.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |